NCT01209182View on ClinicalTrials.gov

In Vitro Detection of Tissue Abnormality

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

October 15, 2010

Primary Completion Date

December 13, 2011

Study Completion Date

January 9, 2012

Conditions
Breast Cancer Female
Interventions
DEVICE

Testing a new device (LS BioPath TOUCH) on excised tissue

Measurements are obtained with test device on excised tissue.

Trial Locations (1)

94117

St. Mary's, San Francisco

Sponsors

Lead Sponsor

LS BioPath
All Listed Sponsors
lead

LS BioPath

INDUSTRY

NCT01209182 - In Vitro Detection of Tissue Abnormality | Biotech Hunter | Biotech Hunter